Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Shares Traded Last Trade
  18.00 1.24% 1,474.40 5,455,287 16:29:59
Bid Price Offer Price High Price Low Price Open Price
1,474.80 1,475.60 1,477.60 1,450.00 1,452.20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 33,754.00 6,221.00 93.90 15.7 73,976
Last Trade Time Trade Type Trade Size Trade Price Currency
17:48:32 O 21,083 1,457.156 GBX

Glaxosmithkline (GSK) Latest News (6)

More Glaxosmithkline News
Glaxosmithkline Takeover Rumours
Smart Money!
GSK is a large holding in the following funds:
 Fund  Percentage of Fund  Last Updated 
 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC 4.60% 2020-08-31
 BMO UK HIGH INCOME TRUST PLC 6.66% 2020-08-31
 BMO CAPITAL AND INCOME INVESTMENT TRUST PLC 3.80% 2020-08-31
 JUPITER UK GROWTH INVESTMENT TRUST PLC 4.60% 2020-08-31

Glaxosmithkline (GSK) Discussions and Chat

Glaxosmithkline (GSK) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Glaxosmithkline trades in real-time

Glaxosmithkline (GSK) Top Chat Posts

DateSubject
27/9/2020
09:20
Glaxosmithkline Daily Update: Glaxosmithkline Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker GSK. The last closing price for Glaxosmithkline was 1,456.40p.
Glaxosmithkline Plc has a 4 week average price of 1,428.60p and a 12 week average price of 1,428.60p.
The 1 year high share price is 1,857p while the 1 year low share price is currently 1,328.60p.
There are currently 5,017,363,927 shares in issue and the average daily traded volume is 8,789,777 shares. The market capitalisation of Glaxosmithkline Plc is £73,976,013,739.69.
06/7/2020
11:15
abdullla: This is not an RNS,the GSK share price rise today is only by tracking the Ftse not the vaccine news .
05/7/2020
09:57
sarkasm: I think the GSK share price could help you retire early Rupert Hargreaves | Sunday, 5th July, 2020 | More on: GSK Cheerful mature couple sitting and managing expenses at home. Image source: Getty Images Of all the 100 different stocks in the FTSE 100, I think the GSK (LSE: GSK) share price has more potential to help you retire early than most. It all comes down to the company’s defensive nature. GSK share price growth Healthcare is one of the world’s most defensive markets. The treatments and products produced by GSK will always be required, and as the population grows, so will demand. But there’s more to GSK that its existing portfolio of drugs and medications. The company also spends billions of pounds every year researching new treatments. These products are designed to combat existing diseases and viruses, as well as new threats. The group is always trying to think of new ways to treat old problems and to address new issues. Management also considers acquisitions regularly. These efforts should help the company maintain its edge in the global pharmaceutical industry, not just in the short term, but in the long run as well. This is the primary reason why the GSK share price could make an excellent buy-and-forget investment. Its products will always be in demand, and demand will only grow over the long run. That means to a certain extent the business runs itself. The company’s consumer pharmaceuticals division is another positive factor. Management is planning to spin off this business in the near term, which could create a windfall for shareholders. A special dividend or shares in the business may be distributed to existing GSK share price holders. Income returns It’s also good news for income seekers. GSK’s defensive business model means that the company has a relatively stable and predictable income stream from operations. This supports an attractive dividend yield on the GSK share price. Indeed, over the past few months, many FTSE 100 businesses have been forced to cut or eliminate their dividends to conserve cash in the coronavirus crisis. GSK is one of the few companies in the index that has not taken this course of action. As a result, at the time of writing the stock supports a dividend yield of 4.9%, above the FTSE 100 average of around 4%. This looks set to continue as the dividend is well covered by earnings per share. The dividend cover stands at 1.5. Retire early All of the above suggests that the GSK share price may be an excellent buy for any investor’s retirement portfolio. Over the long term, earnings per share should grow at least in line with inflation. That implies the company can achieve long-run earnings growth of 3% or more. Coupled with its 4.9% dividend yield, these numbers infer that the stock can produce total returns of 7.9% in the long term. This rate of return is more than enough to help you grow your financial nest egg. According to my calculations, an investment of £200 a month growing at a rate of 7.9% per annum could grow to be worth as much as £300,000 after 30 years. The Motley Fool
07/5/2020
09:03
gateside: GSK share price goes nowhere... It's like Bond that pays 5% yieldMeanwhile AZN is low yield and has had stellar share price growth.Very contrasting performances.I hold both.
18/2/2020
22:23
montedawnster: Perhaps you might all like to stick to the program and discuss GSK share price here. You are chattering like a women's night out.
13/12/2019
00:05
abdullla: Big rise in the pound £1=$1.35 and rising,how is this going to hit GSK share price at the open ?
18/10/2019
15:11
tradermichael: Seems increasingly that the GSK share price is driven not by the markets, not by sales, not by pipeline products or business development or corporate actions, but by the short-term £/USD exchange rate!
19/12/2018
16:33
wbecki: WOW in space of 7 minutes GSK share price worth 75p less!!!! What changed? Or was it a typo? montyhedge 19 Dec '18 - 11:23 - 18655 of 18691 Looked more into it, GSK great deal 1750p here we come. Walsmley on CNBC 30 minutes time, first interview. 80p dividend at least for 2019, then looks like could be increased, yippee. This deal is the transforming deal GSK been looking for. montyhedge 19 Dec '18 - 11:30 - 18656 of 18691 1675p here we come, I reckon, Walsmley CNBC 12pm London time, 7am New York time, first interview. Should create a lot of buying interest.
23/11/2018
16:40
barbel3: hi guys so if the dollar drops to the pound does that mean its better for gsk share price just out of interest cheers
02/11/2018
14:05
jadeticl3: What was it that caused the GSK share price to leap 50p on the day of the results announcement, but then fall by 90p. And then by more thereafter?
02/10/2018
08:37
mr woodentop: Blimey - sounds like the daily express yesterday with 'pound goes ballistic'. It was up 0.3%. Today it is down by about the same amount. The GSK share price, although affected by the £ should not be totally dependent on it. The BOD's actions should be making it rise over the mid to long term. Jury is still out on that one though! keep taking the divis
Glaxosmithkline share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200927 23:00:53